Loading...
Loading...
Jefferies initiated coverage on
Sarepta Therapeutics IncSRPT with a Hold rating. The target price for Sarepta Therapeutics is set to $28. Sarepta Therapeutics shares closed at $24.23 on Thursday.
Analysts at BMO Capital initiated initiated coverage on
TransCanada Corporation (USA)TRP with a Outperform rating. TransCanada shares closed at $34.24 on Thursday.
Jefferies initiated coverage on
PTC Therapeutics, Inc. PTCT with a Hold rating. The target price for PTC Therapeutics is set to $26. PTC Therapeutics shares closed at $24.99 on Thursday.
Analysts at Brean Capital initiated coverage of
Xtant Medical Holdings IncXTNT with a Buy rating. The target price for Xtant Medical Holdings is set to $10. Xtant Medical Holdings shares closed at $3.30 on Thursday.
Analysts at Jefferies initiated coverage on
Ignyta Inc RXDX with a Buy rating. The target price for Ignyta is set to $18. Ignyta shares closed at $10.02 on Thursday.
Jefferies initiated coverage on
Alnylam Pharmaceuticals, Inc.ALNY with a Buy rating. The target price for Alnylam Pharmaceuticals is set to $107. Alnylam Pharmaceuticals shares closed at $75.37 on Thursday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in